Pfizer halts gene therapy trial following child's death

Tragic

Highlights

Pfizer paused an experimental gene therapy trial after a child died from a cardiac arrest.
The trial was for a one-off gene therapy treatment for muscular dystrophy, set to be one of the most expensive drugs in the world.
The tragic death has raised concerns about the safety of gene therapy treatments for young children.

Opinions

You've reached the end